miR-155 expression and function in leukemic stem cells
The paper studied how miR-155 is expressed in clearly defined leukemic stem cell (LSC) populations and tested whether miR-155 regulates LSC function in acute myeloid leukemia (AML). The authors found that miR-155 is regulating LSC self-renewal and quiescence, clarifying its potential role in maintaining LSC properties, while noting prior reports that elevated miR-155 in FLT3-ITD AML can be independent of FLT3-ITD signaling. A limitation explicitly stated in the provided text is that the study was addressing an existing uncertainty about LCS-specific expression and function rather than evaluating related clinical contexts in the abstract. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
788 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- europepmc
- last seen: 2026-05-20T01:45:00.602351+00:00
- unpaywall
- last seen: 2026-06-04T02:00:05.705006+00:00